491 related articles for article (PubMed ID: 16337154)
1. Critical role of PI3-kinase/Akt activation in the PARP inhibitor induced heart function recovery during ischemia-reperfusion.
Kovacs K; Toth A; Deres P; Kalai T; Hideg K; Gallyas F; Sumegi B
Biochem Pharmacol; 2006 Feb; 71(4):441-52. PubMed ID: 16337154
[TBL] [Abstract][Full Text] [Related]
2. Remifentanil Preconditioning Reduces Postischemic Myocardial Infarction and Improves Left Ventricular Performance via Activation of the Janus Activated Kinase-2/Signal Transducers and Activators of Transcription-3 Signal Pathway and Subsequent Inhibition of Glycogen Synthase Kinase-3β in Rats.
Qiao S; Mao X; Wang Y; Lei S; Liu Y; Wang T; Wong GT; Cheung CW; Xia Z; Irwin MG
Crit Care Med; 2016 Mar; 44(3):e131-45. PubMed ID: 26468894
[TBL] [Abstract][Full Text] [Related]
3. Effect of poly(ADP-ribose) polymerase inhibitors on the ischemia-reperfusion-induced oxidative cell damage and mitochondrial metabolism in Langendorff heart perfusion system.
Halmosi R; Berente Z; Osz E; Toth K; Literati-Nagy P; Sumegi B
Mol Pharmacol; 2001 Jun; 59(6):1497-505. PubMed ID: 11353811
[TBL] [Abstract][Full Text] [Related]
4. Akt activation induced by an antioxidant compound during ischemia-reperfusion.
Toth A; Halmosi R; Kovacs K; Deres P; Kalai T; Hideg K; Toth K; Sumegi B
Free Radic Biol Med; 2003 Nov; 35(9):1051-63. PubMed ID: 14572608
[TBL] [Abstract][Full Text] [Related]
5. The role of Akt and mitogen-activated protein kinase systems in the protective effect of poly(ADP-ribose) polymerase inhibition in Langendorff perfused and in isoproterenol-damaged rat hearts.
Pálfi A; Tóth A; Kulcsár G; Hantó K; Deres P; Bartha E; Halmosi R; Szabados E; Czopf L; Kálai T; Hideg K; Sümegi B; Tóth K
J Pharmacol Exp Ther; 2005 Oct; 315(1):273-82. PubMed ID: 15951400
[TBL] [Abstract][Full Text] [Related]
6. Resveratrol prevents CA1 neurons against ischemic injury by parallel modulation of both GSK-3β and CREB through PI3-K/Akt pathways.
Simão F; Matté A; Pagnussat AS; Netto CA; Salbego CG
Eur J Neurosci; 2012 Oct; 36(7):2899-905. PubMed ID: 22817531
[TBL] [Abstract][Full Text] [Related]
7. Prevalent role of Akt and ERK activation in cardioprotective effect of Ca(2+) channel- and beta-adrenergic receptor blockers.
Kovacs K; Hanto K; Bognar Z; Tapodi A; Bognar E; Kiss GN; Szabo A; Rappai G; Kiss T; Sumegi B; Gallyas F
Mol Cell Biochem; 2009 Jan; 321(1-2):155-64. PubMed ID: 18975057
[TBL] [Abstract][Full Text] [Related]
8. PARP inhibition prevents postinfarction myocardial remodeling and heart failure via the protein kinase C/glycogen synthase kinase-3beta pathway.
Palfi A; Toth A; Hanto K; Deres P; Szabados E; Szereday Z; Kulcsar G; Kalai T; Hideg K; Gallyas F; Sumegi B; Toth K; Halmosi R
J Mol Cell Cardiol; 2006 Jul; 41(1):149-59. PubMed ID: 16716347
[TBL] [Abstract][Full Text] [Related]
9. Ischaemic post-conditioning protects both adult and aged Sprague-Dawley rat heart from ischaemia-reperfusion injury through the phosphatidylinositol 3-kinase-AKT and glycogen synthase kinase-3beta pathways.
Yin Z; Gao H; Wang H; Li L; Di C; Luan R; Tao L
Clin Exp Pharmacol Physiol; 2009 Aug; 36(8):756-63. PubMed ID: 19207715
[TBL] [Abstract][Full Text] [Related]
10. PARP inhibition delays transition of hypertensive cardiopathy to heart failure in spontaneously hypertensive rats.
Bartha E; Solti I; Kereskai L; Lantos J; Plozer E; Magyar K; Szabados E; Kálai T; Hideg K; Halmosi R; Sumegi B; Toth K
Cardiovasc Res; 2009 Aug; 83(3):501-10. PubMed ID: 19443425
[TBL] [Abstract][Full Text] [Related]
11. Isoflurane postconditioning prevents opening of the mitochondrial permeability transition pore through inhibition of glycogen synthase kinase 3beta.
Feng J; Lucchinetti E; Ahuja P; Pasch T; Perriard JC; Zaugg M
Anesthesiology; 2005 Nov; 103(5):987-95. PubMed ID: 16249673
[TBL] [Abstract][Full Text] [Related]
12. Curcumin protects against regional myocardial ischemia/reperfusion injury through activation of RISK/GSK-3β and inhibition of p38 MAPK and JNK.
Jeong CW; Yoo KY; Lee SH; Jeong HJ; Lee CS; Kim SJ
J Cardiovasc Pharmacol Ther; 2012 Dec; 17(4):387-94. PubMed ID: 22396328
[TBL] [Abstract][Full Text] [Related]
13. Morphine preconditioning confers cardioprotection in doxorubicin-induced failing rat hearts via ERK/GSK-3β pathway independent of PI3K/Akt.
He SF; Jin SY; Wu H; Wang B; Wu YX; Zhang SJ; Irwin MG; Wong TM; Zhang Y
Toxicol Appl Pharmacol; 2015 Nov; 288(3):349-58. PubMed ID: 26296503
[TBL] [Abstract][Full Text] [Related]
14. Nerve growth factor protects the ischemic heart via attenuation of the endoplasmic reticulum stress induced apoptosis by activation of phosphatidylinositol 3-kinase.
Wei K; Liu L; Xie F; Hao X; Luo J; Min S
Int J Med Sci; 2015; 12(1):83-91. PubMed ID: 25552923
[TBL] [Abstract][Full Text] [Related]
15. Rosuvastatin postconditioning protects isolated hearts against ischemia-reperfusion injury: The role of radical oxygen species, PI3K-Akt-GSK-3β pathway, and mitochondrial permeability transition pore.
Liu CW; Yang F; Cheng SZ; Liu Y; Wan LH; Cong HL
Cardiovasc Ther; 2017 Feb; 35(1):3-9. PubMed ID: 27580017
[TBL] [Abstract][Full Text] [Related]
16. Pivotal role of Akt activation in mitochondrial protection and cell survival by poly(ADP-ribose)polymerase-1 inhibition in oxidative stress.
Tapodi A; Debreceni B; Hanto K; Bognar Z; Wittmann I; Gallyas F; Varbiro G; Sumegi B
J Biol Chem; 2005 Oct; 280(42):35767-75. PubMed ID: 16115861
[TBL] [Abstract][Full Text] [Related]
17. Effect of pressure overload on cardioprotection via PI3K-Akt: comparison of postconditioning, insulin, and pressure unloading.
Mozaffari MS; Liu JY; Schaffer SW
Am J Hypertens; 2010 Jun; 23(6):668-74. PubMed ID: 20300072
[TBL] [Abstract][Full Text] [Related]
18. Diabetes mellitus abrogates erythropoietin-induced cardioprotection against ischemic-reperfusion injury by alteration of the RISK/GSK-3β signaling.
Ghaboura N; Tamareille S; Ducluzeau PH; Grimaud L; Loufrani L; Croué A; Tourmen Y; Henrion D; Furber A; Prunier F
Basic Res Cardiol; 2011 Jan; 106(1):147-62. PubMed ID: 20981553
[TBL] [Abstract][Full Text] [Related]
19. Impact of a novel cardioprotective agent on the ischaemia-reperfusion-induced Akt kinase activation.
Toth A; Kovacs K; Deres P; Halmosi R; Czopf L; Hanto K; Kalai T; Hideg K; Sumegi B; Toth K
Biochem Pharmacol; 2003 Dec; 66(11):2263-72. PubMed ID: 14609750
[TBL] [Abstract][Full Text] [Related]
20. Soluble epoxide hydrolase inhibition ameliorates proteinuria-induced epithelial-mesenchymal transition by regulating the PI3K-Akt-GSK-3β signaling pathway.
Liang Y; Jing Z; Deng H; Li Z; Zhuang Z; Wang S; Wang Y
Biochem Biophys Res Commun; 2015 Jul 17-24; 463(1-2):70-5. PubMed ID: 25986738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
